STEPHENS INC /AR/ - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 350 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
STEPHENS INC /AR/ ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$244,877
-28.1%
5,138
-34.6%
0.00%
-20.0%
Q1 2024$340,428
-15.4%
7,853
-1.3%
0.01%
-28.6%
Q4 2023$402,443
+18.5%
7,955
+6.3%
0.01%0.0%
Q3 2023$339,520
+10.2%
7,485
-0.3%
0.01%
+16.7%
Q2 2023$307,971
+17.4%
7,506
+2.2%
0.01%
+20.0%
Q1 2023$262,403
-0.8%
7,342
+4.8%
0.01%0.0%
Q4 2022$264,503
-34.5%
7,003
-23.3%
0.01%
-44.4%
Q3 2022$404,000
-6.3%
9,125
-21.6%
0.01%0.0%
Q2 2022$431,000
-7.3%
11,644
-7.2%
0.01%
+12.5%
Q1 2022$465,000
-13.7%
12,552
-29.1%
0.01%0.0%
Q4 2021$539,000
-24.0%
17,701
-16.3%
0.01%
-27.3%
Q3 2021$709,000
-30.7%
21,141
-17.5%
0.01%
-26.7%
Q2 2021$1,023,000
-9.5%
25,638
+1.9%
0.02%
-21.1%
Q1 2021$1,131,000
-23.4%
25,156
-3.7%
0.02%
-26.9%
Q4 2020$1,476,000
+45.4%
26,109
+22.0%
0.03%
+30.0%
Q3 2020$1,015,000
-20.4%
21,398
-1.1%
0.02%
-25.9%
Q2 2020$1,275,000
+20.9%
21,628
-3.1%
0.03%
-3.6%
Q1 2020$1,055,000
-24.2%
22,311
-3.2%
0.03%
-3.4%
Q4 2019$1,392,000
+6.3%
23,039
+5.4%
0.03%0.0%
Q3 2019$1,310,000
-9.0%
21,869
-2.3%
0.03%
-12.1%
Q2 2019$1,439,000
-17.7%
22,394
+3.9%
0.03%
-19.5%
Q1 2019$1,749,000
+44.8%
21,548
-3.6%
0.04%
+20.6%
Q4 2018$1,208,000
+2.7%
22,351
-2.0%
0.03%
+17.2%
Q3 2018$1,176,00022,7980.03%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Sicart Associates LLC 367,360$14,768,00010.67%
BB BIOTECH AG 7,461,295$299,944,0009.81%
TANAKA CAPITAL MANAGEMENT INC 83,399$3,353,0007.39%
DOWLING & YAHNKE LLC 675,843$27,169,0002.89%
Opus Point Partners Management, LLC 78,900$3,172,0002.35%
Motley Fool Asset Management LLC 259,000$10,412,0002.25%
ARK Investment Management 127,563$5,128,0001.48%
Motley Fool Wealth Management, LLC 325,965$13,104,0001.26%
PINNACLE ASSOCIATES LTD 1,514,710$60,891,0001.16%
Bellevue Group AG 205,253$8,251,0001.10%
View complete list of IONIS PHARMACEUTICALS INC shareholders